Spaventa Andrew (CIK 1859701) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-02-25). Recent activity: Sell OMIC (325 shares), Sell OMIC (5,271 shares), Sell OMIC (137,629 shares), Sell OMIC (85 shares), Buy OMIC (1,907 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-25 | Singular Genomics Systems, Inc. (OMIC) | Chief Executive Officer | Sell | 325 | $0 |
| 2025-02-25 | Singular Genomics Systems, Inc. (OMIC) | Chief Executive Officer | Sell | 5,271 | $0 |
| 2025-02-25 | Singular Genomics Systems, Inc. (OMIC) | Chief Executive Officer | Sell | 137,629 | $0 |
| 2025-02-25 | Singular Genomics Systems, Inc. (OMIC) | Chief Executive Officer | Sell | 85 | $0 |
| 2025-02-14 | Singular Genomics Systems, Inc. (OMIC) | Chief Executive Officer | Buy | 1,907 | $0 |
| 2025-02-14 | Singular Genomics Systems, Inc. (OMIC) | Chief Executive Officer | Sell | 800 | $15,912 |
| 2025-02-14 | Singular Genomics Systems, Inc. (OMIC) | Chief Executive Officer | Sell | 1,107 | $0 |
| 2025-02-14 | Singular Genomics Systems, Inc. (OMIC) | Chief Executive Officer | Buy | 1,107 | $0 |
Source: SEC Form 4 filings · as of 2025-02-25